PubMed for id: 961

Year	Number of Results
1990	1
1992	1
1993	1
1994	2
1996	2
1997	1
1999	7
2001	4
2002	9
2003	9
2004	11
2005	7
2006	6
2007	4
2008	10
2009	11
2010	9
2011	7
2012	15
2013	12
2014	13
2015	19
2016	14
2017	16
2018	9
2019	21
2020	25
2021	32
2022	25
2023	22
2024	7

1

CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.

Luo X, Mo J, Zhang M, Huang W, Bao Y, Zou R, Yao L, Yuan L. Luo X, et al. World J Surg Oncol. 2024 Feb 6;22(1):44. doi: 10.1186/s12957-024-03308-6. World J Surg Oncol. 2024. PMID: 38317230 Free PMC article.

2

CD47 expression in urothelial carcinoma and its correlation with histopathological findings.

Çoban G, Yıldız P, Şahin N, Ersöz C, Toprak A, Ünver N, Elagöz Ş. Çoban G, et al. Indian J Cancer. 2023 Oct 1;60(4):458-463. doi: 10.4103/ijc.ijc_644_21. Epub 2023 Nov 30. Indian J Cancer. 2023. PMID: 38078465 Free article.

3

Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer.

Wang Q, Feng C, Chen Y, Peng T, Li Y, Wu K, Pu X, Chen H, Liu J. Wang Q, et al. J Immunol Res. 2023 Sep 9;2023:2473075. doi: 10.1155/2023/2473075. eCollection 2023. J Immunol Res. 2023. PMID: 37719086 Free PMC article.

4

CD47 blockade ameliorates autoimmune vasculitis via efferocytosis of neutrophil extracellular traps.

Shiratori-Aso S, Nakazawa D, Kudo T, Kanda M, Ueda Y, Watanabe-Kusunoki K, Nishio S, Iwasaki S, Tsuji T, Masuda S, Tomaru U, Ishizu A, Atsumi T. Shiratori-Aso S, et al. JCI Insight. 2023 Aug 8;8(15):e167486. doi: 10.1172/jci.insight.167486. JCI Insight. 2023. PMID: 37368493 Free PMC article.

5

[Latest Findings on the Role of CD47 in Tumor Immune Evasion and Related Targeted Therapies].

Jie XL, Kong YY, Zhou GB. Jie XL, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):455-461. doi: 10.12182/20230560101. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37248568 Free PMC article. Review. Chinese.

6

CD47 expression is critical for CAR T-cell survival in vivo.

Beckett AN, Chockley P, Pruett-Miller SM, Nguyen P, Vogel P, Sheppard H, Krenciute G, Gottschalk S, DeRenzo C. Beckett AN, et al. J Immunother Cancer. 2023 Mar;11(3):e005857. doi: 10.1136/jitc-2022-005857. J Immunother Cancer. 2023. PMID: 36918226 Free PMC article.

7

Reprograming immune microenvironment modulates CD47 cancer stem cells in hepatocellular carcinoma.

Abd El-Fattah EE, Selim HM. Abd El-Fattah EE, et al. Int Immunopharmacol. 2022 Dec;113(Pt B):109475. doi: 10.1016/j.intimp.2022.109475. Epub 2022 Nov 23. Int Immunopharmacol. 2022. PMID: 36435064 Review.

8

Significance of CD47 expression in endometrial carcinoma.

Sahin N, Coban G, Unver N, Arici DS, Kilic G, Toluk O. Sahin N, et al. Indian J Pathol Microbiol. 2022 Oct-Dec;65(4):856-859. doi: 10.4103/ijpm.ijpm_223_21. Indian J Pathol Microbiol. 2022. PMID: 36308193 Free article.

9

The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy.

Votava M, Bartolini R, Capkova L, Smetanova J, Jiri V Jr, Kuchar M, Kalfert D, Plzak J, Bartunkova J, Strizova Z. Votava M, et al. BMC Cancer. 2022 Sep 28;22(1):1021. doi: 10.1186/s12885-022-10114-4. BMC Cancer. 2022. PMID: 36171566 Free PMC article.

10

Single vesicle analysis of CD47 association with integrins and tetraspanins on extracellular vesicles released by T lymphoblast and prostate carcinoma cells.

Kaur S, Livak F, Daaboul G, Anderson L, Roberts DD. Kaur S, et al. J Extracell Vesicles. 2022 Sep;11(9):e12265. doi: 10.1002/jev2.12265. J Extracell Vesicles. 2022. PMID: 36107309 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

303 results

Results by year